Association of the APOE ε4 allele with disease activity in multiple sclerosis

OBJECTIVES Allelic variants of the APOE gene are known to influence the course of many neurological diseases and there is increasing evidence that apolipoprotein E (APOE) is a pivotal component in reinnervation and dendritic remodelling after neuronal injury. Previous studies did not show significant differences in the APOE allele frequencies in multiple sclerosis compared with controls but did not examine for correlation with disease severity. This study explores the relation of APOE genotypes with the disease severity. METHODS Ninety five patients with multiple sclerosis were studied. Age of onset, type, and activity of the disease were recorded prospectively and genotyping was performed according to standard protocols. RESULTS APOE allele frequencies of the group as a whole, the relapsing group, or the primary progressive group were not significantly different from those reported from matched historical controls. The ε4 allele was found to be more common in patients with a more aggressive type of multiple sclerosis (odds ratio=2.95, p=0.03). CONCLUSIONS Although APOE does not seem to be implicated in the early pathogenesis of the disease, patients possessing the ε4 allele might have a reduced capacity for neuronal remodelling after relapses.

[1]  D. Rubinsztein,et al.  Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. , 1994, Molecular and cellular probes.

[2]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[3]  E Brisch,et al.  The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.

[4]  J. Powell,et al.  Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease , 1996, The Lancet.

[5]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[6]  P. Sham,et al.  Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. , 1996, Lancet.

[7]  A. Ludolph,et al.  Lack of association of apolipoprotein E ϵ4 allele with bulbar‐onset motor neuron disease , 1997 .

[8]  N. Relkin,et al.  The National Institute on Aging/Alzheimer's Association Recommendations on the Application of Apolipoprotein E Genotyping to Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[9]  A. Ludolph,et al.  Lack of association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. , 1997, Annals of neurology.

[10]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[11]  Thomas Arendt,et al.  Plastic Neuronal Remodeling Is Impaired in Patients with Alzheimer’s Disease Carrying Apolipoprotein ε4 Allele , 1997, The Journal of Neuroscience.

[12]  J. Poirier Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.

[13]  E. Masliah,et al.  ALTERATIONS IN APOLIPOPROTEIN E EXPRESSION DURING AGING AND NEURODEGENERATION , 1996, Progress in Neurobiology.

[14]  G. Aimard,et al.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.

[15]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[16]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[17]  A. Saunders,et al.  Head injury, amyloid beta and Alzheimer's disease. , 1995, Nature medicine.

[18]  M A Pericak-Vance,et al.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.

[19]  B. Fontaine,et al.  Apolipoprotein E Polymorphism in Multiple Sclerosis , 1998, Annals of clinical biochemistry.